Gargoyle Investment Advisor’s Jazz Pharmaceuticals JAZZ Stock Holding History

Gargoyle Investment Advisor’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$659K	Hold	4,415	–	–	1.02%	52
2019 Q3	$566K	Hold	4,415	–	–	0.72%	62
2019 Q2	$629K	Hold	4,415	–	–	0.7%	71
2019 Q1	$631K	Buy	+4,415	New	+$576K	0.61%	78
2018 Q3	–	Sell	-2,623	Closed	-$452K	–	101
2018 Q2	$452K	Sell	2,623 -2,081	-44%	-$340K	0.25%	82
2018 Q1	$710K	Buy	4,704 +1,081	+30%	+$159K	0.29%	80
2017 Q4	$488K	Buy	+3,623	New	+$502K	0.19%	116
2017 Q3	–	Sell	-1,323	Closed	-$206K	–	186
2017 Q2	$206K	Buy	+1,323	New	+$202K	0.08%	170
2014 Q2	–	Sell	-4,400	Closed	-$610K	–	146
2014 Q1	$610K	Sell	4,400 -1,270	-22%	-$191K	0.27%	78
2013 Q4	$718K	Buy	+5,670	New	+$587K	0.34%	67
2013 Q3	–	Sell	-42,537	Closed	-$2.92M	–	114
2013 Q2	$2.92M	Buy	+42,537	New	+$2.6M	1.48%	19

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Gargoyle Investment Advisor's JAZZ Position: Q4 2019 in Review

Gargoyle Investment Advisor held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2019 at 4,415 shares worth $659K. The position accounts for 1.02% of the portfolio, ranked #52.

Gargoyle Investment Advisor first reported a position in JAZZ in Q2 2013 and has held it in 11 quarters since. The position peaked at $2.92M in Q2 2013. 446 funds tracked by Wall St. Rank hold JAZZ as of Q4 2019.

Gargoyle Investment Advisor held 4,415 shares of Jazz Pharmaceuticals worth $659K as of Q4 2019.
Gargoyle Investment Advisor left its Jazz Pharmaceuticals share count unchanged in Q4 2019.
Jazz Pharmaceuticals made up 1.02% of Gargoyle Investment Advisor's portfolio in Q4 2019, its #52 holding.
Gargoyle Investment Advisor first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 11 quarters since.
Gargoyle Investment Advisor's Jazz Pharmaceuticals position peaked at $2.92M in Q2 2013.
446 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2019, filed 18 Feb 2020.